80
report
Creating a Nonprofit Marketplace for Shelved Drugs: Lessons from a Pilot Project
Many promising medicines, despite strong safety data and pharmaceutical characteristics, are discon
tinued by drug companies for nonscientific reasons, including strategic, organizational, and financial considerations.
+ Read More
report
Share the Data: Overcoming Trade-Offs in Tech Regulation
DOWNLOAD SUM
report
Spare Tire? Stock Markets and Systemic Banking Crises
Do stock markets act as a “spare tire” during banking crises by providing an alternative form of co
rporate financing when the banking system goes flat?
+ Read More
report
Framing the Issues: De-Risking and Its Consequences for Global Commerce and the Financial System
On March 4, 2015, the Milken Institute Center for Financial Markets hosted a day-long roundtable,&n
bsp;Framing the Issues: De-Risking and Its Consequences for Global Commerce and the Financial System, with AML/CFT policymakers, regulators, fina
+ Read More
report
Hedging Pipeline Risk in Pharma: FDA Swaps and Annuities
The cost of capital to conduct medical R&D is high because investors must be compensated with s
ignificant returns to offset the risky and long drug-development process.
+ Read More
report
Macroprudential Policy and Financial Stability: Where Do We Stand?
With the global economy gaining momentum following its recovery since 2008, and the new U.S.
report
Nonprofits: A Growing Force in Drug Development
Shepherding a drug from discovery to the market is a complex process that involves many actors.
report
Patient-Focused Drug Development Meetings: Smart Practices from Community Leaders
FasterCures, a center of the Milken Institute, designed this guide for patient advocacy organizatio
ns that are interested in hosting, or are currently planning, an externally led patient-focused drug development (PFDD)
+ Read More
report
GBM: Giving Smarter
Glioblastoma Multiforme (GBM) is an aggressive malignant brain tumor involving glial cells of the b
rain. At the time of this report, nearly 15,000 people were diagnosed with GBM each year in the United States and Europe.
+ Read More
report
The Asset Management Industry, Systemic Risk, and Macroprudential Policy
In the aftermath of the 2007-2008 financial crisis, new legislation and regulations have pressured
banks and insurance companies to reduce their size, leverage, and riskier lines of business in order to avoid another too-big-to-fail debacle.
+ Read More
report
ESG Ratings: The Road Ahead
MI REVIEW ARTICLE
report
State Technology and Science Index 2016: Sustaining Americas Innovation Economy
As the Great Recession recedes in our rearview mirrors, it is becoming ever more apparent that inno
vative activities are determining an increasing proportion of the long-term economic growth of cities, metropolitan areas, regions, states, and even natio
+ Read More